Diabetes Care Center, Salinas, California 93901, USA.
Diabetes Technol Ther. 2010 Feb;12(2):105-8. doi: 10.1089/dia.2009.0096.
Both pramlintide and insulin pump waveforms separately provide improved post-meal glucose control. However, when used together there may be a mismatch in actions leading to hypoglycemia. We studied the three currently available waveforms and a "modified combination wave" (MC) in pramlintide-treated patients. The MC was a "square" (SQ) wave combined with a "standard" (ST) bolus that was delayed 1 h into the mealtime.
Using the CGMS Gold (Medtronics, Northridge, CA) we measured the glucose response 0-4 h after the beginning of a meal and 15 min after the initiation of the insulin bolus wave and pramlintide (60 microg), bolus. Pump-treated type 1 diabetes subjects were randomized to one bolus waveform for one full day of three meals and then crossed over to the other bolus waveforms. In the first study nine subjects were randomized to the ST, SQ, or "combination" (C) wave consisting of a ST wave at the beginning of a SQ wave. In the second study nine subjects were randomized to SQ or MC.
With ST and C waves glucose fell approximately 40 mg/dL 0-2 h post-meal and then returned to baseline by the fourth hour. Initially isoglycemic, the SQ wave increased approximately 20 mg/dL in the late meal period. The MC demonstrated minimal (approximately 10 mg/dL) change during the entire post-meal period.
For currently available insulin pump bolus waves, SQ and MC may be least likely to cause hypoglycemia in pramlintide-treated patients.
普兰林肽和胰岛素泵波形分别提供了改善餐后血糖控制的作用。然而,当它们一起使用时,可能会出现行动上的不匹配,导致低血糖。我们研究了目前可用的三种波形和普兰林肽治疗患者的“改良组合波”(MC)。MC 是一种“方形”(SQ)波与“标准”(ST)推注波相结合,该波在进餐时间延迟 1 小时后开始。
使用 CGMS Gold(美敦力,加利福尼亚州北岭),我们测量了进餐开始后 0-4 小时和胰岛素推注波及普兰林肽(60 微克)推注后 15 分钟的血糖反应。接受泵治疗的 1 型糖尿病患者被随机分配到一种推注波形式,用于三餐的一整天,然后交叉到其他推注波形式。在第一项研究中,9 名受试者被随机分配到 ST、SQ 或“组合”(C)波,即 SQ 波在 ST 波开始时组成。在第二项研究中,9 名受试者被随机分配到 SQ 或 MC。
在 ST 和 C 波中,餐后 0-2 小时血糖下降约 40mg/dL,然后在第四小时恢复到基线。初始时等血糖,SQ 波在晚餐后期增加约 20mg/dL。MC 在整个餐后期间显示出最小的(约 10mg/dL)变化。
对于目前可用的胰岛素泵推注波,SQ 和 MC 可能是在普兰林肽治疗患者中引起低血糖的可能性最小的。